
               
               
               CLINICAL PHARMACOLOGY:

               
                  Polymyxin B attacks gram-negative bacilli, including virtually all strains of Pseudomonas aeruginosa and H influenzae species.

                  Bacitracin is active against most gram-positive bacilli and cocci including hemolytic streptococci.

               
               
            
         